Literature DB >> 29744668

Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder.

Erlend Glasø Faltinsen1, Ole Jakob Storebø2,3, Christian Gluud4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29744668     DOI： 10.1007/s00787-018-1164-6

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  13 in total

1.  Conceptual and technical challenges in network meta-analysis.

Authors:  Andrea Cipriani; Julian P T Higgins; John R Geddes; Georgia Salanti
Journal:  Ann Intern Med       Date:  2013-07-16       Impact factor: 25.391

2.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

3.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

4.  Network meta-analysis: the highest level of medical evidence?

Authors:  Erlend G Faltinsen; Ole Jakob Storebø; Janus C Jakobsen; Kim Boesen; Theis Lange; Christian Gluud
Journal:  BMJ Evid Based Med       Date:  2018-03-14

Review 5.  Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Authors:  Sarah C O S Padilha; Suzane Virtuoso; Fernanda S Tonin; Helena H L Borba; Roberto Pontarolo
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-19       Impact factor: 4.785

Review 6.  Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Authors:  Salima Punja; Larissa Shamseer; Lisa Hartling; Liana Urichuk; Ben Vandermeer; Jane Nikles; Sunita Vohra
Journal:  Cochrane Database Syst Rev       Date:  2016-02-04

7.  Plea for routinely presenting prediction intervals in meta-analysis.

Authors:  Joanna IntHout; John P A Ioannidis; Maroeska M Rovers; Jelle J Goeman
Journal:  BMJ Open       Date:  2016-07-12       Impact factor: 2.692

8.  The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.

Authors:  Ferrán Catalá-López; Brian Hutton; Amparo Núñez-Beltrán; Matthew J Page; Manuel Ridao; Diego Macías Saint-Gerons; Miguel A Catalá; Rafael Tabarés-Seisdedos; David Moher
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

Review 9.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

10.  Efficacy of new generation antidepressants: differences seem illusory.

Authors:  A C Del Re; Glen I Spielmans; Christoph Flückiger; Bruce E Wampold
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.